Tesamorelin and PT-141 (bremelanotide). Both FDA-approved. We don't offer BPC-157, sermorelin, ipamorelin, or other gray-market peptides — the ones the FDA has flagged for enforcement. Real protocol, real compliance, defensible offering.
Clinical protocol, prescribing, and follow-up — all run by Access Plus Medical providers.
Patient completes intake. A provider confirms the protocol fits — only FDA-approved peptides are offered.
The appropriate FDA-approved peptide is prescribed and routed to a specialty pharmacy.
Dosing, check-ins, and refills run with provider oversight throughout.
Patient completes a branded intake with history and goals.
An Access Plus Medical provider reviews eligibility and prescribes when appropriate.
The prescription is routed to the right pharmacy and shipped to the patient.
Check-ins, monitoring, and refills run on schedule with oversight throughout.
We're onboarding a small first cohort. Tell us what you're building — we'll confirm fit before either of us spends more time.
Build.MD is in early access. We're working with a focused group of operators across providers, medspas, fitness, brands, and enterprise before opening broadly. Tell us what you're building; we'll come back within the next business day if there's a fit.